Please ensure Javascript is enabled for purposes of website accessibility

Protagonist Therapeutics, Inc. Common Stock(PTGX)

Nasdaq Global Market

PTGX
Protagonist Therapeutics, Inc. Common Stock Stock Quote
$49.26 $0.18 0.4%
Price as of August 3, 2021, 4:00 p.m. ET View Interactive PTGX Charts

Protagonist Therapeutics, Inc. Common Stock

Interactive Chart


Compare PTGX Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
PTGX
Protagonist Therapeutics, Inc. Common Stock
$49.26 $2B 198.7% 321.0%
EDIT
$42.11 $3B 33.4% 68.5%
CRLBF
$11.01 $6B 85.4%
BLUE
$25.11 $2B -60.0% -53.3%
ALKS
$27.86 $4B 49.1% -43.0%

News & Analysis: Protagonist Therapeutics, Inc. Common Stock

All

Market Moves

Earnings




Biotech’s Year-End To-Do List

The remaining weeks of December are chock-full of clinical trial results and FDA approval decisions that savvy investors can take advantage of.